City of McAllen & MedCare End Relationship

Uninterrupted ambulance service will continue in McAllen

Translate to Spanish or other 102 languages!

On Monday, January 23, 2023, the McAllen City Commission rejected the unreasonable and unjustified demands made by MedCare EMS and accepted MedCare EMS’ notice to terminate its contract for the delivery of emergency medical services to the city effective February 22, 2023. Image for illustration purposes
On Monday, January 23, 2023, the McAllen City Commission rejected the unreasonable and unjustified demands made by MedCare EMS and accepted MedCare EMS’ notice to terminate its contract for the delivery of emergency medical services to the city effective February 22, 2023. Image for illustration purposes

Mega Doctor News

- Advertisement -

On Monday, January 23, 2023, the McAllen City Commission rejected the unreasonable and unjustified demands made by MedCare EMS and accepted MedCare EMS’ notice to terminate its contract for the delivery of emergency medical services to the city effective February 22, 2023.

During the last several months, the City of McAllen has repeatedly met with, discussed at length, and provided MedCare with reasonable options to provide emergency medical services.  Despite these intensive efforts by City of McAllen administration, to date, no resolution has been reached. The decision to accept MedCare EMS’s notification to terminate the contract was made only after careful consideration and exhaustion of all reasonable options. 

The City of McAllen has a duty to preserve and protect the public health and safety of its residents in a fiscally responsible manner. As such, the City of McAllen has made the necessary arrangements to provide uninterrupted emergency medical services with a well-established ambulance service which employs over 127 clinical professionals certified or licensed by the State of Texas, and a long history of ambulance service, including emergency preparedness disaster responses. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Moderna and Merck Report Positive Phase 3 Results for Personalized Cancer Therapy

Moderna and Merck have reached a major clinical milestone after their investigational individualized cancer therapy, combined with Merck’s Keytruda, produced positive results in a Phase 3 study involving patients with high-risk melanoma.

STHS Scores Fourth Consecutive 5-Star Rating for Diabetic Care

Diabetes remains one of the nation’s most pressing health challenges, with a disease once largely associated with older adults now affecting younger populations at an alarming rate.

STHS to Examine Back Pain in New “South Texas Healthy Living” Episode, Aug, 30th

Back pain is the most common pain condition reported by Americans, affecting nearly 65 million U.S. adults annually, with an estimated 16 million living with chronic symptoms, according to the Centers for Disease Control and Prevention (CDC).

Physicians Urge Updating Child Vaccinations Before School Starts

Texas physicians have an important message for parents as the new school year is about to begin: Ensure your children are current on all their necessary vaccinations. 
- Advertisement -